Williams Financial LLC Invests $867,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Williams Financial LLC acquired a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 6,495 shares of the financial services provider’s stock, valued at approximately $867,000.

A number of other large investors have also added to or reduced their stakes in the stock. Future Financial Wealth Managment LLC purchased a new stake in shares of iShares Biotechnology ETF in the first quarter worth $27,000. Bbjs Financial Advisors LLC purchased a new position in iShares Biotechnology ETF in the second quarter worth about $31,000. Pacifica Partners Inc. lifted its stake in shares of iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after buying an additional 130 shares in the last quarter. Crewe Advisors LLC grew its holdings in shares of iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after buying an additional 78 shares during the last quarter. Finally, YHB Investment Advisors Inc. bought a new stake in shares of iShares Biotechnology ETF during the first quarter valued at approximately $37,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $147.81 on Friday. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.17. The company has a 50 day moving average of $145.10 and a 200 day moving average of $138.28.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.